These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10738472)

  • 1. Preventing hepatitis C virus transmission in Australians who inject drugs.
    Watson KJ
    Med J Aust; 2000 Jan; 172(2):55-6. PubMed ID: 10738472
    [No Abstract]   [Full Text] [Related]  

  • 2. Eradication of hepatitis C infection: the importance of targeting people who inject drugs.
    Hellard M; Doyle JS; Sacks-Davis R; Thompson AJ; McBryde E
    Hepatology; 2014 Feb; 59(2):366-9. PubMed ID: 23873507
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving the quality of needle and syringe programmes: an overlooked strategy for preventing hepatitis C among people who inject drugs.
    Leicht A
    BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S8. PubMed ID: 25252714
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment as prevention: the breaking of taboos is required in the fight against hepatitis C among people who inject drugs.
    Bruggmann P
    Hepatology; 2013 Nov; 58(5):1523-5. PubMed ID: 23728921
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
    Bruggmann P; Grebely J
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who: four ways to reduce hepatitis infections in people who inject drugs.
    Cent Eur J Public Health; 2012 Sep; 20(3):207. PubMed ID: 23285521
    [No Abstract]   [Full Text] [Related]  

  • 7. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Copeman M
    Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs.
    Martinello M; Dore GJ; Matthews GV; Grebely J
    Infect Dis Clin North Am; 2018 Jun; 32(2):371-393. PubMed ID: 29778261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to hepatitis C care for people who inject drugs and people in prisons.
    Oru E; Verster A
    Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):662-663. PubMed ID: 31362917
    [No Abstract]   [Full Text] [Related]  

  • 10. Social inclusion and hepatitis C: exploring new possibilities for prevention.
    Treloar C; Valentine K; Fraser S
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):397-404. PubMed ID: 21504397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV revisited: preventing the spread of blood-borne viruses among injecting drug users.
    Wodak A; Crofts N
    Aust J Public Health; 1994 Sep; 18(3):239-41. PubMed ID: 7841248
    [No Abstract]   [Full Text] [Related]  

  • 12. Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses.
    Lazarus JV; Safreed-Harmon K; Stumo SR; Jauffret-Roustide M; Maticic M; Reic T; Schatz E; Tallada J; Harris M;
    Int J Drug Policy; 2017 Sep; 47():47-50. PubMed ID: 28689856
    [No Abstract]   [Full Text] [Related]  

  • 13. Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.
    Grebely J; Bruneau J; Bruggmann P; Harris M; Hickman M; Rhodes T; Treloar C; ;
    Int J Drug Policy; 2017 Sep; 47():26-33. PubMed ID: 28888558
    [No Abstract]   [Full Text] [Related]  

  • 14. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
    Sullivan LG
    Med J Aust; 1999 Aug; 171(3):165-6. PubMed ID: 10474613
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C infection among injecting drug users in Scotland: stemming the flow.
    Goldberg D; Taylor A; Hutchinson S; McMenamin J
    Scott Med J; 2000 Oct; 45(5):131-2. PubMed ID: 11130293
    [No Abstract]   [Full Text] [Related]  

  • 16. Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.
    Davis SM; Daily S; Kristjansson AL; Kelley GA; Zullig K; Baus A; Davidov D; Fisher M
    Harm Reduct J; 2017 May; 14(1):25. PubMed ID: 28514954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Law MG; Batey RG
    Med J Aust; 2003 Mar; 178(5):197-8. PubMed ID: 12603178
    [No Abstract]   [Full Text] [Related]  

  • 18. New developments and opportunities for preventing hepatitis C virus (HCV) among people who use and inject drugs-announcing an Addiction series.
    Hickman M; Grebely J; Bruneau J; Coffin P; Degenhardt L; Hutchinson S; Larney S; Martin N; Treloar C; Vickerman P
    Addiction; 2017 Jul; 112(7):1126-1127. PubMed ID: 28586551
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of hepatitis C. How to update the pioneer work done by Eugène Jamot?].
    Coton T
    Presse Med; 2003 Sep; 32(29):1349-50. PubMed ID: 14534495
    [No Abstract]   [Full Text] [Related]  

  • 20. Needle exchange programmes should do more to prevent transmission of hepatitis C virus.
    Ford C
    BMJ; 1996 Sep; 313(7059):752. PubMed ID: 8819457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.